S&P 500   4,080.11
DOW   34,589.77
QQQ   293.36
The AP Interview: IMF head urges China to end mass lockdowns
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Santa Claus Rally? Here’s What Needs to Happen
3 Dividend Growers With Good 2023 Growth Prospects
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Build Your Quality of Life by Investing in Your Lifestyle
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Dark Clouds Are Gathering For Cloud Stocks 
Hormel: Is This The Time To Buy?
S&P 500   4,080.11
DOW   34,589.77
QQQ   293.36
The AP Interview: IMF head urges China to end mass lockdowns
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Santa Claus Rally? Here’s What Needs to Happen
3 Dividend Growers With Good 2023 Growth Prospects
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Build Your Quality of Life by Investing in Your Lifestyle
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Dark Clouds Are Gathering For Cloud Stocks 
Hormel: Is This The Time To Buy?
S&P 500   4,080.11
DOW   34,589.77
QQQ   293.36
The AP Interview: IMF head urges China to end mass lockdowns
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Santa Claus Rally? Here’s What Needs to Happen
3 Dividend Growers With Good 2023 Growth Prospects
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Build Your Quality of Life by Investing in Your Lifestyle
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Dark Clouds Are Gathering For Cloud Stocks 
Hormel: Is This The Time To Buy?
S&P 500   4,080.11
DOW   34,589.77
QQQ   293.36
The AP Interview: IMF head urges China to end mass lockdowns
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Santa Claus Rally? Here’s What Needs to Happen
3 Dividend Growers With Good 2023 Growth Prospects
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Build Your Quality of Life by Investing in Your Lifestyle
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Dark Clouds Are Gathering For Cloud Stocks 
Hormel: Is This The Time To Buy?
OTCMKTS:AOLS

Aeolus Pharmaceuticals - AOLS Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
620 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Aeolus Pharmaceuticals

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.

Receive AOLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeolus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AOLS Stock News Headlines

Aeolus Pharmaceuticals Inc
Aeolus Pharmaceuticals, Inc. (AOLS)
Aeolus Pharmaceuticals Inc.
See More Headlines

Receive AOLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeolus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AOLS Company Calendar

Last Earnings
8/14/2017
Today
12/01/2022
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AOLS
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.94

Key Executives

  • Mr. John L. Mcmanus (Age 58)
    Chief Exec. Officer and Pres
    Comp: $460.33k
  • Mr. Christopher Stanley
    VP of Operations













AOLS Stock - Frequently Asked Questions

How were Aeolus Pharmaceuticals' earnings last quarter?

Aeolus Pharmaceuticals, Inc. (OTCMKTS:AOLS) posted its quarterly earnings data on Monday, August, 14th. The biopharmaceutical company reported ($0.01) earnings per share (EPS) for the quarter. The biopharmaceutical company had revenue of $0.01 million for the quarter.

What other stocks do shareholders of Aeolus Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aeolus Pharmaceuticals investors own include iBio (IBIO), Myriad Genetics (MYGN), Synergy Pharmaceuticals (SGYP), Titan Pharmaceuticals (TTNP), ADOMANI (ADOM), Agritek (AGTK), Akers Biosciences (AKER), Argos Therapeutics (ARGSQ), Arena Pharmaceuticals (ARNA) and Biohaven (BHVN).

What is Aeolus Pharmaceuticals' stock symbol?

Aeolus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "AOLS."

How do I buy shares of Aeolus Pharmaceuticals?

Shares of AOLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How can I contact Aeolus Pharmaceuticals?

Aeolus Pharmaceuticals' mailing address is 26361 CROWN VALLEY PARKWAY SUITE 150, MISSION VIEJO CA, 92691. The official website for the company is www.aeoluspharma.com. The biopharmaceutical company can be reached via phone at (949) 481-9825, via email at info@amstock.com, or via fax at 949-481-9829.

This page (OTCMKTS:AOLS) was last updated on 12/1/2022 by MarketBeat.com Staff